Lv71
4160 积分 2024-04-21 加入
Neuromodulation for chronic pain
5天前
已完结
Suzetrigine, a Non-Opioid NaV1.8 Inhibitor for Treatment of Moderate-to-Severe Acute Pain: Two Phase 3 Randomized Clinical Trials
5天前
已完结
Suzetrigine: First Approval
5天前
已完结
Sodium Channel Inhibitors in Clinical Development for Pain Management: A Focused Review
5天前
已完结
Targeting sodium channels — challenges for acute pain and the leap to chronic pain
11天前
已完结
Clinical Care Pathway for the Risk Stratification and Management of Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease
14天前
已完结
Efficacy and safety of ervogastat alone and in combination with clesacostat in patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis and F2–F3 fibrosis (MIRNA): results from a phase 2, randomised, double-blind, double-dummy study
15天前
已完结
Targeting Factor XI for Safer Anticoagulation: Emerging Data and Future Directions
20天前
已完结
Antisense oligonucleotide DGAT-2 inhibitor, ION224, for metabolic dysfunction-associated steatohepatitis (ION224-CS2): results of a 51-week, multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
1个月前
已完结
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis
1个月前
已完结
皖公网安备34019202002308
